{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:56:23Z","timestamp":1789674983870,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This post hoc analysis of a Japanese cohort study aimed to identify factors that could assist in early prediction of opioid-induced constipation (OIC). The onset of OIC and the predictive accuracy (sensitivity, specificity, likelihood ratios, and positive predictive values) of early constipation symptoms for OIC onset were assessed within 6 days of weak opioid initiation. Of 63 patients (\u2265\u200918 years) without prior constipation who initiated weak opioids for chronic musculoskeletal pain, 23.8% of them met the Rome IV diagnostic criteria for OIC onset after 3 days. Straining (34.9%), incomplete evacuation (25.4%), and lumpy\/hard stools (15.9%) were the common symptoms, with the highest positive likelihood ratio of 2.4 for lumpy\/hard stools. Decreased defecation frequency is commonly used for the diagnosis of OIC; however, it was reported in only 1.6% of patients at day 3. The positive predictive value of developing OIC by day 14, based on the early symptoms at day 3, was 70.0% for lumpy\/hard stools, 59.1% for straining, 56.3% for sensation of incomplete evacuation, and 72.7% for self-awareness of constipation. Early observation of symptoms such as lumpy\/hard stools and self-awareness of constipation could be useful for early prediction of the risk of developing OIC after initiation of weak opioids.<\/jats:p>","DOI":"10.1038\/s41598-026-45169-x","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T07:45:00Z","timestamp":1774856700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early detection of opioid-induced constipation in patients initiating weak opioids for chronic non-cancer pain"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7878-2557","authenticated-orcid":false,"given":"Yasuhide","family":"Morioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Koretaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihomi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Sonohata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asbj\u00f8rn Mohr","family":"Drewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"45169_CR1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00540-025-03559-x","volume":"39","author":"A Kanai","year":"2025","unstructured":"Kanai, A. et al. Executive summary of the guideline for prescribing opioid analgesics for chronic non-cancer pain (third edition) by the Japan Society of Pain Clinicians. J. Anesth. 39, 677\u2013702 (2025).","journal-title":"J. Anesth."},{"key":"45169_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/2050640618818305","volume":"7","author":"AD Farmer","year":"2019","unstructured":"Farmer, A. D. et al. Pathophysiology and management of opioid-induced constipation: European expert consensus statement. United Eur. Gastroenterol. J. 7, 7\u201320 (2019).","journal-title":"United Eur. Gastroenterol. J."},{"key":"45169_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/2040622315627801","volume":"7","author":"AD Nelson","year":"2016","unstructured":"Nelson, A. D. & Camilleri, M. Opioid-induced constipation: advances and clinical guidance. Ther. Adv. Chronic Dis. 7, 121\u2013134 (2016).","journal-title":"Ther. Adv. Chronic Dis."},{"key":"45169_CR4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s40122-022-00392-y","volume":"11","author":"M Sonohata","year":"2022","unstructured":"Sonohata, M. et al. A survey of the incidence of constipation in patients with chronic non-cancer pain using opioid analgesics in Japan. Pain Ther. 11, 845\u2013859 (2022).","journal-title":"Pain Ther."},{"key":"45169_CR5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/1756283X15578608","volume":"8","author":"AD Nelson","year":"2015","unstructured":"Nelson, A. D. & Camilleri, M. Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities. Ther. Adv. Gastroenterol. Rev. 8, 206\u2013220 (2015).","journal-title":"Ther. Adv. Gastroenterol. Rev."},{"key":"45169_CR6","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.cgh.2017.05.014","volume":"15","author":"M Camilleri","year":"2018","unstructured":"Camilleri, M., Lembo, A. & Katzka, D. Opioids in gastroenterology: treating adverse effects and creating therapeutic benefits. Clin. Gastroenterol. Hepatol. 15, 1338\u20131349 (2018).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"45169_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1124\/jpet.108.143438","volume":"327","author":"GR Ross","year":"2009","unstructured":"Ross, G. R., Gabra, B. H. & Dewey, W. L. Akbarali, H. I. Morphine tolerance in the mouse ileum and colon Gracious. J. Pharmacol. Exp. Ther. 327, 561\u2013572 (2009).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"45169_CR8","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.3390\/molecules25112473","volume":"25","author":"S F\u00fcrst","year":"2020","unstructured":"F\u00fcrst, S. et al. On the role of peripheral sensory and gut mu opioid receptors: peripheral analgesia and tolerance. Molecules 25, 2473 (2020).","journal-title":"Molecules"},{"key":"45169_CR9","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1248\/bpb.b21-00474","volume":"44","author":"K Yasufuku","year":"2021","unstructured":"Yasufuku, K. et al. Involvement of the peripheral \u00b5-opioid receptor in tramadol-induced constipation in rodents. Biol. Pharm. Bull. 44, 1746\u20131751 (2021).","journal-title":"Biol. Pharm. Bull."},{"key":"45169_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/bcpt.14067","volume":"135","author":"IM Larsen","year":"2024","unstructured":"Larsen, I. M., Okdahl, T., Mark, E. B., Fr\u00f8kj\u00e6r, J. B. & Drewes, A. M. The influence of tramadol on bowel function: a randomised, placebo-controlled trial. Basic. Clin. Pharmacol. Toxicol. 135, 475\u2013490 (2024).","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"45169_CR11","doi-asserted-by":"publisher","first-page":"17397","DOI":"10.1038\/s41598-025-01770-0","volume":"15","author":"A Hashimoto","year":"2025","unstructured":"Hashimoto, A., Morioka, Y., Wada, S., Koretaka, Y. & Sonohata, M. Incidence of opioid-induced constipation in non-cancer patients using weak opioids for chronic pain in Japan: a cohort study. Sci. Rep. 15, 17397 (2025).","journal-title":"Sci. Rep."},{"key":"45169_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.11154\/pain.39.64","volume":"39","author":"M Kitamura","year":"2024","unstructured":"Kitamura, M., Morioka, Y., Kobayashi, M. & Ushida, T. A web-based survey on the quality of life of patients with opioid induced constipation using weak opioids in chronic non-cancer musculoskeletal pain in Japan. Pain Res. 39, 64\u201375 (2024).","journal-title":"Pain Res."},{"key":"45169_CR13","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","volume":"150","author":"DA Drossman","year":"2016","unstructured":"Drossman, D. A. & Hasler, W. L. Rome IV-Functional GI disorders: disorders of gut-brain interaction. Gastroenterology 150, 1257\u20131261 (2016).","journal-title":"Gastroenterology"},{"key":"45169_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5056\/jnm16214","volume":"23","author":"MJ Schmulson","year":"2017","unstructured":"Schmulson, M. J. & Drossman, D. A. What is new in Rome IV. J. Neurogastroenterol Motil. 23, 151\u2013163 (2017).","journal-title":"J. Neurogastroenterol Motil."},{"key":"45169_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/j.pain.0000000000002024","volume":"162","author":"A Davies","year":"2021","unstructured":"Davies, A. et al. Opioid-induced constipation in patients with cancer: a real-world, multicentre, observational study of diagnostic criteria and clinical features. Pain 162, 309\u2013318 (2021).","journal-title":"Pain"},{"key":"45169_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5056\/jnm17058","volume":"24","author":"JL Poulsen","year":"2018","unstructured":"Poulsen, J. L. et al. Colorectal transit and volume during treatment with prolonged-release oxycodone\/naloxone versus oxycodone plus macrogol 3350. J. Neurogastroenterol Motil. 24, 119\u2013127 (2018).","journal-title":"J. Neurogastroenterol Motil."},{"key":"45169_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nmo.14131","volume":"33","author":"EB Mark","year":"2021","unstructured":"Mark, E. B. et al. Tapentadol results in less deterioration of gastrointestinal function and symptoms than standard opioid therapy in healthy male volunteers. Neurogastroenterol Motil. 33, 1\u201310 (2021).","journal-title":"Neurogastroenterol Motil."},{"key":"45169_CR18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/MEG.0000000000000574","volume":"28","author":"M Nilsson","year":"2016","unstructured":"Nilsson, M. et al. Opioid-induced bowel dysfunction in healthy volunteers assessed with questionnaires and MRI. Eur. J. Gastroenterol. Hepatol. 28, 514\u2013524 (2016).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"45169_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejps.2018.02.008","volume":"117","author":"D Gr\u00f8nlund","year":"2018","unstructured":"Gr\u00f8nlund, D. et al. The impact of naloxegol on anal sphincter function\u2014Using a human experimental model of opioid-induced bowel dysfunction. Eur. J. Pharm. Sci. 117, 187\u2013192 (2018).","journal-title":"Eur. J. Pharm. Sci."},{"key":"45169_CR20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/bcpt.13850","volume":"132","author":"T Okdahl","year":"2023","unstructured":"Okdahl, T. et al. Effects of opium tincture on the enteric and central nervous systems: a randomized controlled trial. Basic. Clin. Pharmacol. Toxicol. 132, 434\u2013448 (2023).","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"45169_CR21","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jpainsymman.2019.11.021","volume":"59","author":"S Fumita","year":"2020","unstructured":"Fumita, S. et al. Patients\u2019 self-assessment of the symptoms and impact of opioid-induced constipation: results from a prospective observational cohort study of Japanese patients with cancer. J. Pain Symptom Manage. 59, 1043\u20131051 (2020).","journal-title":"J. Pain Symptom Manage."},{"key":"45169_CR22","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1111\/nmo.12387","volume":"26","author":"H Ono","year":"2014","unstructured":"Ono, H. et al. Circular muscle contraction in the mice rectum plays a key role in morphine-induced constipation. Neurogastroenterol Motil. 26, 1396\u20131407 (2014).","journal-title":"Neurogastroenterol Motil."},{"key":"45169_CR23","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1007\/s10620-017-4784-7","volume":"62","author":"JL Poulsen","year":"2017","unstructured":"Poulsen, J. L. et al. Prolonged-release oxycodone\/naloxone improves anal sphincter relaxation compared to oxycodone plus macrogol 3350. Dig. Dis. Sci. 62, 3156\u20133166 (2017).","journal-title":"Dig. Dis. Sci."},{"key":"45169_CR24","doi-asserted-by":"crossref","unstructured":"Kumar, L., Barker, C. & Emmanuel, A. Opioid-induced constipation: pathophysiology, clinical consequences, and management. Gastroenterol Res Pract. 2014, 141737 (2014).","DOI":"10.1155\/2014\/141737"},{"key":"45169_CR25","first-page":"125","volume":"16","author":"W Leppert","year":"2012","unstructured":"Leppert, W. The impact of opioid analgesics on the gastrointestinal tract function and the current management possibilities. Contemp. Oncol. 16, 125\u2013131 (2012).","journal-title":"Contemp. Oncol."},{"key":"45169_CR26","doi-asserted-by":"publisher","first-page":"16B","DOI":"10.1155\/2011\/715858","volume":"25","author":"CN Andrews","year":"2011","unstructured":"Andrews, C. N. & Storr, M. The pathophysiology of chronic constipation. Can. J. Gastroenterol. 25, 16B\u201321B (2011).","journal-title":"Can. J. Gastroenterol."},{"key":"45169_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1472-8206.2008.00636.x","volume":"23","author":"HF Miranda","year":"2009","unstructured":"Miranda, H. F., Puig, M. M., Romero, M. A. & Prieto, J. C. Effects of tramadol and dexketoprofen on analgesia and gastrointestinal transit in mice. Fundam Clin. Pharmacol. 23, 81\u201388 (2009).","journal-title":"Fundam Clin. Pharmacol."},{"key":"45169_CR28","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/aje\/kwh072","volume":"159","author":"V Garrigues","year":"2004","unstructured":"Garrigues, V. et al. Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain. Am. J. Epidemiol. 159, 520\u2013526 (2004).","journal-title":"Am. J. Epidemiol."},{"key":"45169_CR29","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.2147\/JPR.S417045","volume":"16","author":"WD Chey","year":"2023","unstructured":"Chey, W. D. et al. Efficacy and safety of naloxegol in patients with chronic non-cancer pain who experience opioid-induced constipation: a pooled analysis of two global, randomized controlled studies. J. Pain Res. 16, 2943\u20132953 (2023).","journal-title":"J. Pain Res."},{"key":"45169_CR30","doi-asserted-by":"publisher","first-page":"e230310","DOI":"10.1001\/jamanetworkopen.2023.0310","volume":"6","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Effects of electroacupuncture for opioid-induced constipation in patients with cancer in China: a randomized clinical trial. JAMA Netw. Open. 6, e230310 (2023).","journal-title":"JAMA Netw. Open."},{"key":"45169_CR31","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1093\/pm\/pnw325","volume":"18","author":"LR Webster","year":"2017","unstructured":"Webster, L. R., Yamada, T. & Arjona Ferreira, J. C. A phase 2b, randomized, double-blind placebo-controlled study to evaluate the efficacy and safety of naldemedine for the treatment of opioid-induced constipation in patients with chronic noncancer pain. Pain Med. 18, 2350\u20132360 (2017).","journal-title":"Pain Med."},{"key":"45169_CR32","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1111\/pme.12437","volume":"15","author":"B Cryer","year":"2014","unstructured":"Cryer, B., Katz, S., Vallejo, R., Popescu, A. & Ueno, R. A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain. Pain Med. 15, 1825\u20131834 (2014).","journal-title":"Pain Med."},{"key":"45169_CR33","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/j.gastro.2018.07.016","volume":"156","author":"SD Crockett","year":"2019","unstructured":"Crockett, S. D. et al. American Gastroenterological Association Institute Guideline on the medical management of opioid-induced constipation. Gastroenterology 156, 218\u2013226 (2019).","journal-title":"Gastroenterology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45169-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45169-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45169-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:08:32Z","timestamp":1781644112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45169-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45169"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45169-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.S. and A.M.D. have received lecture fees from Shionogi & Co., Ltd., Japan. Y.M., Y.K., and S.W. are employees of Shionogi & Co., Ltd., Japan. A.H. has no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10605"}}